Extended-release oxybutynin an effective option in overactive bladder

By  

Inpharma, Vol. 1, Iss. 1303, 2001-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

A Benefit-Risk Assessment of Extended-Release Oxybutynin

By Michel M.C.  

Drug Safety, Vol. 25, Iss. 12, 2002-01 ,pp. : 867-876

Adis International

Access to resources Recommend Favorite

Extended-Release Oxybutynin: A Viewpoint by Rodney U. Anderson

By Leach G.E.  

Drugs & Aging, Vol. 16, Iss. 2, 2000-02 ,pp. : 156-157

Adis International

Access to resources Recommend Favorite

Effect of Antacid on the Pharmacokinetics of Extended-Release Formulations of Tolterodine and Oxybutynin

By Gayatri Sathyan  

Clinical Pharmacokinetics, Vol. 43, Iss. 14, 2004-01 ,pp. : 1059-1068

Adis International

Access to resources Recommend Favorite

Oxybutynin Extended-Release: A Review of its Use in the Management of Overactive Bladder

By Siddiqui M.A.A.   Perry C.M.   Scott L.J.  

Drugs, Vol. 64, Iss. 8, 2004-01 ,pp. : 885-912

Adis International

Access to resources Recommend Favorite